Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia - Wikidata - wikimedia - TriplyDB

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

http://www.wikidata.org/entity/Q26824116

about

Hematopoietic stem cell transplantation for people with ß-thalassaemia major Customizing the genome as therapy for the β-hemoglobinopathies Alternative donor transplant of benign primary hematologic disorders The potential of gene therapy approaches for the treatment of hemoglobinopathies: achievements and challenges Reduction of intramedullary apoptosis after stem cell transplantation in black african variant of pediatric sickle cell anemia.Transplantation tolerance: from theory to clinic.Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.Hematopoietic stem cell transplantation for people with ß-thalassaemia major.Pretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease control High-Resolution Analyses of Human Leukocyte Antigens Allele and Haplotype Frequencies Based on 169,995 Volunteers from the China Bone Marrow Donor Registry Program Haematopoietic stem cell transplantation in Nigerian sickle cell anaemia children patients Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.Management of the thalassemias Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation.Impact of Donor-Specific anti-HLA Antibodies and Donor KIR Characteristics in Haploidentical HSCT for Beta-Thalassemia.Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.Acceptability of In Utero Hematopoietic Cell Transplantation for Sickle Cell Disease.2017 Clinical trials update in new treatments of β-thalassemia.Emerging cellular and gene therapies for congenital anemias.Investigational drugs in phase I and phase II clinical trials for thalassemia.Mixed chimerism evolution is associated with T regulatory type 1 (Tr1) cells in a β-thalassemic patient after haploidentical haematopoietic stem cell transplantation.An LC-MS Assay with Isocratic Separation and On-line Solid Phase Extraction to Improve the Routine Therapeutic Drug Monitoring of Busulfan in Plasma.Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies.Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.Pathophysiology and treatment of patients with beta-thalassemia - an update.Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia.Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations

P2860

Q24193101-7FD813BC-370F-4771-BE5F-594E134F60DB Q26751061-40415EBF-D2A9-4845-B766-D59574B138C3 Q26823398-EA557E9A-716E-496F-817D-6AB99AE7E78D Q28077484-761A37D6-DA8C-47D6-A502-8E9E966D8D9D Q33920142-6063589F-69F1-4F79-BD10-13A9979E6E65 Q34082059-EF045202-3C8C-47CD-BC30-C5B0C90ECACA Q34343785-8F0433B4-9B14-4305-A13C-BB4120C0A6BB Q34546216-7FECF693-BBF7-4D54-8F7A-22FCA1E8AAF0 Q35600557-B4CDAA2C-E5AE-4B80-A52C-D831CD5A7E90 Q35793428-A7036C8D-AE77-4BF3-BEA8-090071E58BD5 Q35898546-3D9D0A14-F7B3-460E-BBB8-090AF402E966 Q35904935-6CC390FC-131F-4284-9E18-BA81BE1EA181 Q36027459-9EC4DFE0-9470-4700-933A-8591FA1E18B1 Q36650481-C95CCA76-712E-4BE1-B3CF-C25C67271BB6 Q36654528-B2C9A710-7DA7-4EAC-B7CD-3D480AD7FF8B Q36870253-F36F99DE-D6EB-4ECE-AE01-2EB6E48D012A Q37623526-68E71065-F41F-415B-BB9F-A4D077FCA5B9 Q37677242-ED5D80AC-D366-4934-A4EA-06A28A95E587 Q38191280-F0666015-0862-4924-BF89-15BF24191922 Q38387292-C9573254-16B8-428E-8A5D-36928035F503 Q38514485-F2A44830-7CA5-41A3-84DA-FB6FB79EDFE0 Q38685531-5A6FF3FE-DE71-4897-8F74-FE80AA4B7FB6 Q38922283-1BF80793-5878-4FB0-BE2E-4676BC395035 Q38993825-704E7CD0-2331-4AD5-8E6B-2583F45EFDC9 Q39328286-2AEDF7F8-365F-497A-BE65-7069B1E380C1 Q41453938-1FFC167D-DDC8-4D99-BB52-B4D042A7ED30 Q42201727-C3E4D102-F5C8-4F9B-877D-33DC9AB4C804 Q45872216-CEF1AF8A-0E50-4619-99D3-89159056108A Q47614537-361A7ECB-BB79-4D03-93E9-9E9F50E6EE0E Q48247015-EBCA6768-D5BC-47E9-B89E-781577A56B41 Q50571229-C95764C8-6FAA-4903-8C9F-F781D1623652 Q54585888-94DCE1C8-428C-474A-85DB-246B9ABC6A09

P2860

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

http://www.wikidata.org/entity/Q26824116

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

@ast

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

@en

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

@nl

type

label

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

@ast

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

@en

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

@nl

prefLabel

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

@ast

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

@en

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

@nl

P1433

Q26824116-70B537C5-4D5B-4690-A530-2FBDD1287945

P1476

Q26824116-FD45EC2C-424F-4A17-B64E-898672E20139

P2093

Q26824116-0AD85F73-A2D7-46ED-BE5F-7EAACA139AFC

Q26824116-45E5F6B3-318F-4F98-8098-6EFB30B4CF7D

Q26824116-87C5BD0B-016F-4A69-BBE5-84537D65EE1E

P2860

Q26824116-0337722E-EA12-47C8-BF7C-707274C84F14

Q26824116-096C917D-D8FC-44EC-AA60-220FF8DE77BC

Q26824116-0C325FED-CEA7-4CBB-BDFF-50E4C5BB1DAD

Q26824116-13C3F196-5148-48B5-AD9E-3200A5946246

Q26824116-18DE2458-3D93-4971-9EA1-9B17D6C78533

Q26824116-1BE04F2C-6547-4B00-BFD6-4C6A366FF38B

Q26824116-2D2CB397-C961-44FB-A60C-8BB02F2A58D0

Q26824116-2D77DB8F-578C-49E9-A305-DF67D76DC59C

Q26824116-313F79F1-DE36-45C2-9CFB-AF57B92AA078

Q26824116-316FCB89-AEEA-4ED1-9DF3-449277F22321

P304

Q26824116-0F462ED6-AE19-4725-871B-5483DDE86F1A

P31

Q26824116-6BCFC25E-63E5-46A7-91F7-2D4197CB63A0

P356

Q26824116-0363A010-DB5F-44DB-8518-20BCDFBE297F

P407

Q26824116-2F8559FD-DA01-438A-98E0-C80F5144D7FA

P433

Q26824116-8FA34C96-2E7D-409E-B700-12E312D03796

P478

Q26824116-8E62EC65-F93B-4105-8CBB-FD332F056793

P50

Q26824116-D354BE23-6EE4-4F9E-B04D-AA18C841DF39

P577

Q26824116-C6E1A0DE-315F-4EBD-8104-89F107C381A7

P5875

Q26824116-C26AEB59-5413-4A4D-9A83-8AB678B6DADE

P698

Q26824116-FD0DD7E4-D6C5-4215-8B40-DB7643725936

P921

Q26824116-5641D1C0-0A8E-45F5-A864-F35E23CAAFAA

P932

Q26824116-F05D539C-C6BC-4962-8C5A-342C732036BD

P356

CSHPERSPECT.A011825

P1433

Cold Spring Harbor Perspectives in Medicine

P1476

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

@en

P2093

Guido Lucarelli

http://www.w3.org/2001/XMLSchema#string

Javid Gaziev

http://www.w3.org/2001/XMLSchema#string

Pietro Sodani

http://www.w3.org/2001/XMLSchema#string

P2860

HLA-matched sibling bone marrow transplantation for β-thalassemia major

T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients

Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide.

Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.

The cure of thalassemia by bone marrow transplantation.

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.

Regulation of human fetal hemoglobin: new players, new complexities.

Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.

Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience.

Advances in the allogeneic transplantation for thalassemia.

P304

a011825

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/CSHPERSPECT.A011825

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224889226

http://www.w3.org/2001/XMLSchema#string

P698

22553502

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

3331690

http://www.w3.org/2001/XMLSchema#string